Product image of Mabelio (Ceftobiprole Medocaril Sodium) supplied by GNH India

Mabelio

Active Ingredient:
Ceftobiprole Medocaril Sodium
Origin:
EU

Mabelio (Ceftobiprole Medocaril Sodium)

Mabelio is an intravenous antibiotic containing Ceftobiprole Medocaril Sodium, used to treat bacterial infections. This medication is manufactured by Advanz Pharma Limited and is available in the EU market.

Manufacturer / TM Owner

Advanz Pharma Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Mabelio is primarily used for the treatment of bacterial infections. It is often prescribed for conditions where bacterial resistance to other antibiotics is a concern. The active ingredient, Ceftobiprole Medocaril Sodium, works by targeting the bacterial cell wall, helping to combat infections effectively. Patients may wonder, 'What is Mabelio used for?' and the answer lies in its broad-spectrum antibacterial properties.

Side Effects

  • Common effects of Mabelio may include mild to moderate reactions at the injection site, such as redness or swelling. Some patients might experience gastrointestinal discomfort or allergic reactions. It is important to monitor for any signs of adverse effects and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

  • Mabelio should be used with caution in patients with a history of allergic reactions to antibiotics. It is essential to follow the prescribed dosage and administration instructions carefully. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Avoid Interactions

  • Mabelio may interact with certain medications, including other antibiotics and drugs that affect kidney function. Alcohol consumption should be avoided as it can exacerbate side effects. Patients should also be cautious when taking medications that are metabolized by the liver, as they may influence the effectiveness of Mabelio.

Frequently Asked Questions

Mabelio is used to treat bacterial infections, particularly those that are resistant to other antibiotics.

Mabelio is administered intravenously, meaning it is delivered directly into the bloodstream through a vein.

Common side effects may include reactions at the injection site, gastrointestinal discomfort, and allergic reactions.

Patients should consult their healthcare provider before taking Mabelio with other medications to avoid potential interactions.

The safety of Mabelio for long-term use should be discussed with a healthcare provider, as it depends on individual health conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ceftobiprole Medocaril Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT